Ceregene is a San Diego-based company specializing in gene delivery technology and neurotrophic factors for the treatment of neurological diseases such as ALS, Alzheimer's disease, Parkinson's disease, and ocular diseases. With a focus on clinical trials and scientific advancements, Ceregene aims to develop innovative therapies that target the underlying causes of these conditions.
Through their pipeline of research and development, Ceregene is dedicated to improving the lives of individuals affected by neurological disorders by harnessing the potential of gene therapy and neurotrophic factors. With a commitment to scientific excellence and a mission to advance the field of neurology, Ceregene is at the forefront of cutting-edge treatments for these debilitating diseases.
Generated from the website